Ortho Clinical Diagnostics
 | |
| Website |
orthoclinical |
|---|---|
Ortho Clinical Diagnostics is a company that makes in vitro diagnostics products. It was created following Johnson and Johnson's acquisition of Eastman Kodak's Clinical Diagnostics Division in 1994 (to form Johnson & Johnson Clinical Diagnostics), which was then merged with Ortho Diagnostic Systems in 1997. Their corporate offices are in Raritan, New Jersey, while their main research and manufacturing facilities are in Rochester, New York. The business has two major segments: Transfusion Medicine which is involved in screening human blood, and Clinical Laboratories, which does a variety of chemical and immunodiagnostic testing.
In 2014, the company was sold to The Carlyle Group for $4.15 billion.[1]
Ortho-Clinical Diagnostics, Inc. (Ortho) unveiled its newly expanded executive leadership team following the acquisition of the company by The Carlyle Group (NASDAQ: CG) from Johnson & Johnson. In his first act as OCD Chairman and Chief Executive Officer, Dr. Martin D. Madaus announced key appointments in finance, operations, legal and commercial to advance strategic sectors of the In Vitro Diagnostics (IVD) business.
References
- ↑ Daneman, Matthew (16 January 2014). "Carlyle to buy Ortho-Clinical for $4.15 billion". Democrat and Chronicle. Retrieved 23 March 2014.